Salud financiera de hoja de balance de Genscript Biotech
Salud financiera controles de criterios 4/6
Genscript Biotech tiene un patrimonio de los accionistas total de $2.0B y una deuda total de $769.7M, lo que sitúa su ratio deuda-patrimonio en 37.7%. Sus activos y pasivos totales son $3.4B y $1.3B respectivamente.
Información clave
37.7%
Ratio deuda-patrimonio
US$769.73m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$1.93b |
| Patrimonio | US$2.04b |
| Total pasivo | US$1.34b |
| Activos totales | US$3.39b |
Actualizaciones recientes sobre salud financiera
Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 13
Is Genscript Biotech (HKG:1548) A Risky Investment?
Nov 21Is Genscript Biotech (HKG:1548) A Risky Investment?
Aug 22Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 02Is Genscript Biotech (HKG:1548) Using Debt Sensibly?
Oct 22Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?
Apr 03Recent updates
Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 13Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%
Mar 13Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 26Is Genscript Biotech (HKG:1548) A Risky Investment?
Nov 21Is Genscript Biotech (HKG:1548) A Risky Investment?
Aug 22Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook
Apr 04Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report
Apr 03Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 02Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate
Feb 07What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?
Dec 14Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate
Nov 09Is Genscript Biotech (HKG:1548) Using Debt Sensibly?
Oct 22Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?
Apr 03Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?
Oct 03Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Sep 07Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)
Aug 16Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Jun 03Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?
May 13Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
Apr 16Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?
Mar 20Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?
Feb 13
Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?
Jan 09Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?
Dec 05Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.4B) de 1548 superan a sus pasivos a corto plazo ($494.8M).
Pasivo a largo plazo: Los activos a corto plazo de 1548 ($2.4B) superan a sus pasivos a largo plazo ($848.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 1548 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 1548 ha crecido de 2.1% a 37.7% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 1548 tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si 1548 tiene suficiente cash runway en caso de que su flujo de caja libre siga creciendo o disminuyendo basado en tasas históricas.